Estimates Revisions Jasper Therapeutics, Inc.
Stocks
JSPR
US4718712023
Biotechnology & Medical Research
|
Delayed
Nasdaq
11:46:51 2026-09-30 EDT
|
5-day change | 1st Jan Change | ||
| 0.6213 USD | -0.66% |
|
+9.62% | -66.05% |
| 09-17 | Jasper Therapeutics, Inc.(NasdaqCM:JSPR) added to NASDAQ Composite Index | CI |
| 09-14 | Jasper Therapeutics, Inc. Appoints Lisa Pitt, Pharm.D., M.S.J. as Senior Vice President | CI |
Turnover - Evolution of Analysts' Estimates
| 1m. Revenue rev. | 1y. Revenue rev. | 1y. EPS revision | ||
|---|---|---|---|---|
 | ||||
| ||||
| ||||
| ||||
| ||||
| ||||
| ||||
| ||||
| ||||
| Average | ||||
| Weighted average by Cap. |
Turnover
- Stock Market
- Stocks
- JSPR Stock
- Consensus Jasper Therapeutics, Inc.
- Estimates Revisions
Select your edition
All financial news and data tailored to specific country editions
